INNOVADERM CRO IS NOW INDERO.

“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience (…)” – An Inmagene Biopharmaceuticals Testimonial

Indero

Indero

Team of Experts

Author picture

Our remarkable team has received high praise from yet another satisfied customer!

“Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.” Duong Nguyen, Head of Clinical Operations at Inmagene Biopharmaceuticals.

“Innovaderm’s profound understanding of alopecia areata and their forward-thinking strategy sets them apart. The team’s detailed explanations, thorough research, and well-considered solutions are commendable, especially in risk mitigation. Our collaboration with Innovaderm has been smooth and cooperative, free from finger-pointing or difficult interactions. Both teams have meshed well, working together towards the best outcomes for the study and the patients. It has been a pleasure, and we look forward to many more successful studies together. We highly recommend Innovaderm for their professionalism and expertise.”

Our commitment to delivering customized solutions and nurturing strong relationships is evident in testimonials like these.

Discover how we can assist you in your upcoming dermatology program!

Need help with your next dermatology or rheumatology study? Tell us a little about your needs.

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.